Overview of progress in hematology in 1981 with special reference to leukocyte.
D015250:Aclarubicin; D000208:Acute Disease; D000328:Adult; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000378:metabolism / Q000627:therapeutic use; D002478:Cells, Cultured; D002648:Child; D003561:Cytarabine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003843:Deoxycytidine Monophosphate / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy*; D007939:Leukemia L1210 / Q000188:drug therapy; D007962:Leukocytes / Q000502:physiology*; D009279:Naphthacenes / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D009279:Naphthacenes; D003561:Cytarabine; D003843:Deoxycytidine Monophosphate; D015250:Aclarubicin; C015019:enocitabine